Non-metastatic breast cancer

被引:0
|
作者
Saglier, J [1 ]
机构
[1] Clin St Jean de Dieu, Paris, France
来源
JOURNAL DE CHIRURGIE | 2005年 / 142卷 / 06期
关键词
breast; diagnosis; treatment; cancer;
D O I
10.1016/S0021-7697(05)80956-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Seen before as a secondary branch in the field of surgery, the surgery of breast cancer is now a fully stand-alone specialty. A number of factors explain this trend: a dramatic increase of incidence, which practically doubled during the past twenty years, an evolution of the surgical practices leading to a "therapeutic coming-down" and, above all, a complexification of indications and elements of classification. The surgeon still remains the first actor of the treatment, often seing the patient in first place, and having by his surgical treatment a key action on the prognosis and the patient's quality of life. Nevertheless, the surgeon is not anymore the only master of the situation, as he once could have been. Breast cancer is now the archetypal disease where a multidisciplinary approach is mandatory at every stage. The aim of this article is to overview the reality of breast cancer at present, trying to clarify the numerous elements of classification, otherwise confusing.
引用
收藏
页码:355 / 366
页数:12
相关论文
共 50 条
  • [31] Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: A systematic review
    Trudeau, M
    Sinclair, SE
    Clemons, M
    CANCER TREATMENT REVIEWS, 2005, 31 (04) : 283 - 302
  • [32] Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis?
    Alieldin, Nelly H.
    Abo-Elazm, Omnia M.
    Bilal, Dalia
    Salem, Eid Salem
    Gouda, Eman
    Elmongy, Magda
    Ibrahim, Amal S.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (01) : 23 - 30
  • [33] Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer
    Pernin, Victor
    Belin, Lisa
    Cottu, Paul
    Bontemps, Patrick
    Lemanski, Claire
    De La Lande, Brigitte
    Baumann, Pierre
    Missohou, Fernand
    Levy, Christelle
    Peignaux, Karine
    Bougnoux, Pierre
    Denis, Fabrice
    Bollet, Marc
    Dendale, Remi
    Vago, Nora Ady
    Campana, Francois
    Fourquet, Alain
    Kirova, Youlia M.
    BREAST, 2014, 23 (06): : 816 - 820
  • [34] Bevacizumab in HER2-negative non-metastatic breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (03): : E93 - E93
  • [35] A psycho-educational group for non-metastatic breast cancer patients
    Gagnon, P
    Gagnon, L
    Charbonneau, C
    Fillion, L
    PSYCHO-ONCOLOGY, 2001, 10 (04) : S41 - S42
  • [36] Neoadjuvant chemotherapy in non-metastatic breast cancer: The surgeon's perspective
    Ofri, A.
    Elstner, K.
    Mann, G. B.
    Kumar, S.
    Warrier, S.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2023, 21 (06): : 356 - 360
  • [37] Disease-free survival in patients with non-metastatic breast cancer
    Diniz, Roberta Wolp
    Guerra, Maximiliano Ribeiro
    Duarte Cintra, Jane Rocha
    Fayer, Vivian Assis
    Bustamante Teixeira, Maria Teresa
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (05): : 407 - 413
  • [38] Transcription phenotype of circulating tumor cells in non-metastatic breast cancer
    Shliakhtunou, Yauheni A.
    Siamionau, Valery M.
    Pobyarzhin, Vyacheslau V.
    CARCINOGENESIS, 2022, 43 (01) : 21 - 27
  • [39] Metabolic abnormalities and survival among patients with non-metastatic breast cancer
    Alexa S. Zimbalist
    Bette J. Caan
    Wendy Y. Chen
    Elizabeth A. Mittendorf
    Deborah A. R. Dillon
    Charles Quesenberry
    Elizabeth M. Cespedes Feliciano
    BMC Cancer, 22
  • [40] Prognostic significance of Nottingham Prognostic Index in non-metastatic breast cancer
    Cihan, Yasemin Benderli
    Sarigoz, Talha
    JOURNAL OF BUON, 2016, 21 (01): : 279 - 279